Ethics and Policies

Publication Ethics, Editorial Policies and Malpractice Statement

1. Introduction

East West Medical College Journal (EWMCJ) is committed to maintaining the highest standards of publication ethics and transparency in scholarly publishing. EWMCJ follows internationally accepted ethical principles and editorial practices recommended by:

  • Committee on Publication Ethics (COPE)
  • International Committee of Medical Journal Editors (ICMJE)
  • World Association of Medical Editors (WAME)
  • World Medical Association (WMA)
  • Declaration of Helsinki
  • Recommendations for Clinical Trial Registration issued by ICMJE

Full text links of all above mentioned sites are stated at the bottom of this page. 

The Editorial Board, reviewers, authors, and publishers are expected to adhere to these ethical standards throughout the publication process.

 

2. Research Ethics and Human Participants

Research involving human participants must comply with internationally accepted ethical principles.

EWMCJ adheres to the ethical principles outlined in the World Medical Association Declaration of Helsinki:

"The Declaration of Helsinki is a statement of ethical principles for medical research involving human subjects, including research on identifiable human material and identifiable data."

Full text available at:

https://www.wma.net/policies-post/wma-declaration-of-helsinki/

Authors must clearly state within the manuscript:

  • Name of the Ethics Committee/Institutional Review Board
  • Approval number/reference number
  • Date of approval

Example:

"Ethical approval was obtained from the Institutional Review Board of East West Medical College Hospital (Approval No: XXXX/2026)."

Studies lacking ethical approval will be rejected.

3. Informed Consent

For studies involving human participants, informed consent is mandatory.

Authors should confirm:

  • Written informed consent was obtained from participants.
  • Participants understood the objectives, risks and benefits of participation.
  • Participants had the right to withdraw at any stage.

For case reports:

  • Written informed consent for publication must be obtained from the patient.

If photographs or identifying information are included, explicit permission for publication must be documented.

Editorial office may request copies of consent forms if necessary.

 

4. Vulnerable Populations

Research involving vulnerable populations requires additional safeguards.

This includes:

  • Children
  • Neonates
  • Cognitively impaired individuals
  • Psychiatric patients
  • Prisoners
  • Economically disadvantaged populations

For minors:

Consent must be obtained from parents or legal guardians.

When appropriate, assent from the child should also be obtained.

Authors should describe these procedures within the Methods section.

 

5. Animal Research

Animal experiments must comply with institutional and national guidelines.

Authors should provide:

  • Name of ethical committee
  • Approval number
  • Compliance with ARRIVE guidelines whenever applicable: Link for full text: https://arriveguidelines.org/arrive-guidelines

Studies involving unnecessary suffering of animals will not be considered.

6. Clinical Trial Registration Policy

EWMCJ supports prospective registration of clinical trials.

Clinical trials should be registered in a publicly accessible registry before recruitment of the first participant.

Acceptable registries include:

  • ClinicalTrials.gov
  • WHO International Clinical Trials Registry Platform (ICTRP): Link: https://www.who.int/tools/clinical-trials-registry-platform
  • ISRCTN Registry: Link: https://www.isrctn.com/
  • National trial registries recognized by WHO: Link: Bangladesh does not have its own standalone, WHO-recognized national clinical trial registry. Instead, researchers in Bangladesh register their trials in recognized international and regional primary registries that feed into the WHO ICTRP Search Portal- Link: WHO ICTRP Search Portal
  • Local Oversight & Approval: Before a clinical trial can begin in Bangladesh, it must receive ethical clearance from the Bangladesh Medical Research Council (BMRC) and regulatory approval from the Ministry of Health's Directorate General of Drug Administration (DGDA).

Authors should provide:

  • Registration number
  • Registry name
  • Date of registration

Example:

Clinical Trial Registration:
 NCT01234567

Unregistered clinical trials may not be accepted unless adequately justified.

7. Authorship Criteria

EWMCJ follows ICMJE recommendations.

Authorship should be based on substantial contributions to:

  1. Study conception or design.
  2. Acquisition, analysis or interpretation of data.
  3. Drafting or critically revising the manuscript.
  4. Final approval of the submitted version.
  5. Accountability for all aspects of the work.

All five conditions should be met.

Contributors not fulfilling authorship criteria should be acknowledged.

Ghost authorship, guest authorship and honorary authorship are unacceptable.

8. Conflict of Interest

All authors must disclose financial or non-financial conflicts of interest.

Examples include:

  • Employment
  • Consultancies
  • Grants
  • Honoraria
  • Patents
  • Stock ownership

If no conflicts exist, authors should declare:

"The authors declare no conflict of interest."

Editors and reviewers must also disclose potential conflicts.

9. Funding Disclosure

Authors must declare all funding sources.

Example:

"This study was supported by the Bangladesh Medical Research Council."

If no funding was received:

"No external funding was received."

10. Data Availability Statement

Authors are encouraged to provide information regarding accessibility of datasets.

Examples:

"The data supporting the findings are available from the corresponding author upon reasonable request."

or

"All relevant data are included within the manuscript."

11. Artificial Intelligence Policy

Use of Artificial Intelligence tools should be disclosed.

AI systems cannot be listed as authors.

Authors remain fully responsible for:

  • Accuracy
  • Integrity
  • Originality
  • Scientific validity

Example statement:

"ChatGPT was used for language editing purposes only."

 

12. Plagiarism Policy

EWMCJ maintains zero tolerance toward plagiarism.

Submitted manuscripts may be screened using plagiarism detection software.

Plagiarism includes:

  • Direct copying
  • Self-plagiarism
  • Duplicate publication
  • Data fabrication
  • Data falsification

Manuscripts with significant plagiarism may be rejected immediately.

Serious misconduct may be reported to affiliated institutions.

13. Duplicate and Redundant Publication

Manuscripts submitted to EWMCJ must not be:

  • Previously published
  • Simultaneously submitted elsewhere
  • Under review by another journal

Authors must disclose overlapping publications.

14. Editorial Independence

Editorial decisions are based exclusively on:

  • Scientific merit
  • Originality
  • Relevance
  • Methodological quality
  • Ethical compliance

Editorial decisions are independent of commercial considerations.

Publishers do not influence editorial decisions.

 

15. Peer Review Policy

EWMCJ employs a double-blind peer review process.

Each manuscript is evaluated by at least two independent reviewers.

Reviewers are expected to:

  • Maintain confidentiality
  • Declare conflicts of interest
  • Provide objective and constructive comments

Editors make final decisions based on reviewer recommendations.

16. Corrections Policy

EWMCJ is committed to maintaining the integrity of the scholarly record.

Corrections may be issued for:

  • Minor errors
  • Author affiliation changes
  • Inaccuracies affecting interpretation

Corrections will be linked to the original publication.

17. Retraction Policy

Articles may be retracted if evidence demonstrates:

  • Data fabrication
  • Data falsification
  • Ethical violations
  • Plagiarism
  • Duplicate publication
  • Unreliable findings

Retraction notices will:

  • Remain permanently available
  • Clearly identify reasons for retraction
  • Link to the original article

EWMCJ follows COPE Retraction Guidelines- Link: https://publicationethics.org/guidance/guideline/retraction-guidelines

18. Expression of Concern

Editors may issue an Expression of Concern when:

  • Misconduct allegations are under investigation.
  • Findings are potentially unreliable.
  • Institutional inquiries are ongoing.

Such notices remain until investigations are concluded.

19. Complaints and Appeals

Authors may appeal editorial decisions.

Appeals should be submitted to:

Editor-in-Chief

East West Medical College Journal

Email: editorial.ewmcj@gmail.com

Appeals will be reviewed independently.

Complaints involving publication ethics shall be handled according to COPE recommendations.

20. Publication Malpractice

The following practices are unacceptable:

  • Plagiarism
  • Data fabrication
  • Data falsification
  • Citation manipulation
  • Authorship manipulation
  • Undisclosed conflicts of interest
  • Peer review manipulation

Appropriate investigations will be conducted whenever misconduct is suspected.

21. Ethical Responsibilities of Editors

Editors shall:

  • Act fairly and impartially.
  • Preserve confidentiality.
  • Avoid conflicts of interest.
  • Maintain editorial independence.
  • Uphold scientific integrity.

Editors shall follow COPE Core Practices- Link: https://publication-ethics.org/resources/cope-core-practices/

22. Ethical Responsibilities of Reviewers

Reviewers should:

  • Maintain confidentiality.
  • Provide objective assessments.
  • Identify uncited work.
  • Report ethical concerns.
  • Complete reviews within agreed timelines.

23. Ethical Responsibilities of Authors

Authors must ensure:

  • Accuracy of data
  • Originality
  • Proper citations
  • Ethical approvals
  • Informed consent
  • Disclosure of conflicts

Authors are responsible for correcting errors discovered after publication.

24. Declarations of AI Use:

E.g: 

 

This manuscript was prepared through the combined contributions of all author(s), including contributions to the study design, data, content development, results, interpretation, and related scholarly work. The author(s) acknowledge the use of Grammarly and ChatGPT to assist with grammar checking, language refinement, reference formatting. These AI-assisted tools were not used as authors and did not replace the intellectual contributions or scholarly judgment of the author(s). All AI-assisted outputs, including content, references, and interpretations, were carefully reviewed, revised, verified, and approved by the author(s). The author(s) accept full responsibility for the accuracy, integrity, and final content of the manuscript.

 

References and International Guidelines

Committee on Publication Ethics (COPE): https://publicationethics.org/

ICMJE Recommendations: https://www.icmje.org/

World Association of Medical Editors (WAME): https://wame.org/

Declaration of Helsinki: https://www.wma.net/policies-post/wma-declaration-of-helsinki/

ClinicalTrials.gov: https://clinicaltrials.gov/

WHO ICTRP: https://trialsearch.who.int/